BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2454950)

  • 1. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis.
    Murphy BF; Kirszbaum L; Walker ID; d'Apice AJ
    J Clin Invest; 1988 Jun; 81(6):1858-64. PubMed ID: 2454950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
    Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
    Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SC5b-7 complex: formation, isolation, properties, and subunit composition.
    Podack ER; Kolb WP; Müller-Eberhard HJ
    J Immunol; 1977 Dec; 119(6):2024-9. PubMed ID: 410885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of terminal complement components S-protein and SP-40,40 in renal biopsies.
    Murphy BF; Davies DJ; Morrow W; d'Apice AJ
    Pathology; 1989 Oct; 21(4):275-8. PubMed ID: 2483750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Function of terminal complement complex and control protein in renal disease (renal localization and serum levels of S protein, and detection of the SC5b-9 complex)].
    Kojima H; Ohi H; Seki M; Hatano M
    Nihon Jinzo Gakkai Shi; 1986 Nov; 28(11):1449-56. PubMed ID: 2434699
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
    Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE
    Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human seminal clusterin (SP-40,40). Isolation and characterization.
    O'Bryan MK; Baker HW; Saunders JR; Kirszbaum L; Walker ID; Hudson P; Liu DY; Glew MD; d'Apice AJ; Murphy BF
    J Clin Invest; 1990 May; 85(5):1477-86. PubMed ID: 2185274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
    Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
    Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HDL consisting of SP-40,40, apo A-I, and lipids in the formation of SMAC of complement.
    Choi-Miura NH; Sakamoto T; Tobe T; Nakano Y; Tomita M
    J Biochem; 1993 Apr; 113(4):484-7. PubMed ID: 8514737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of clusterin in the epimembranous deposits of passive Heymann nephritis.
    Eddy AA; Fritz IB
    Kidney Int; 1991 Feb; 39(2):247-52. PubMed ID: 2002638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis.
    Yamakami K; Yoshizawa N; Wakabayashi K; Takeuchi A; Tadakuma T; Boyle MD
    Methods; 2000 Jun; 21(2):185-97. PubMed ID: 10816380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney.
    Saunders JR; Aminian A; McRae JL; O'Farrell KA; Adam WR; Murphy BF
    Kidney Int; 1994 Mar; 45(3):817-27. PubMed ID: 8196284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of brain clusterin.
    Oda T; Pasinetti GM; Osterburg HH; Anderson C; Johnson SA; Finch CE
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1131-6. PubMed ID: 7980587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases.
    Rus HG; Niculescu F; Nanulescu M; Cristea A; Florescu P
    Clin Exp Immunol; 1986 Jul; 65(1):66-72. PubMed ID: 3539428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the anticomplementary agent, K-76 monocarboxylic acid, on experimental immune complex glomerulonephritis in rats.
    Iida H; Izumino K; Asaka M; Takata M; Mizumura Y; Sasayama S
    Clin Exp Immunol; 1987 Jan; 67(1):130-4. PubMed ID: 3497741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal complement complex (TCC) and S-protein (vitronectin) on follicular dendritic cells in human lymphoid tissues.
    Halstensen TS; Mollnes TE; Brandtzaeg P
    Immunology; 1988 Oct; 65(2):193-7. PubMed ID: 2461343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement.
    Choi NH; Nakano Y; Tobe T; Mazda T; Tomita M
    Int Immunol; 1990; 2(5):413-7. PubMed ID: 2150757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.
    Høgåsen K; Jansen JH; Mollnes TE; Hovdenes J; Harboe M
    J Clin Invest; 1995 Mar; 95(3):1054-61. PubMed ID: 7883953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SP-40,40 is an inhibitor of C5b-6-initiated haemolysis.
    Murphy BF; Saunders JR; O'Bryan MK; Kirszbaum L; Walker ID; d'Apice AJ
    Int Immunol; 1989; 1(5):551-4. PubMed ID: 2489042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.